Cardiol Therapeutics
CRDL----
Cardiol Therapeutics (CRDL)
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Cardiol Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$7.38525.75%
Forecast & RatingStrong buy
5analysts
- Strong buy60.00%
- Buy40.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 20 at 09:41 AM
First Berlin reiterates Buy on Cardiol Therapeutics, keeps USD 7.5 target price
- Tip Ranks · Jul 14 at 11:15 AM
H.C. Wainwright Remains a Buy on Cardiol Therapeutics (CRDL)
- PUBT · Jul 14 at 06:27 AM
Cardiol Therapeutics says Phase II recurrent pericarditis data for CardiolRx published in JAHA
- prnewswire · Jul 9 at 06:28 AM
07:27 ETCardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit
- Tip Ranks · Jun 25 at 07:19 AM
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM
- StockTitan · Jun 24 at 10:27 PM
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders | CRDL Stock News
